Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
algorithm
Amplatzer device
aneurysm
aneurysm, intracranial
aneurysm, intracranial, treatment of
angiography, cerebral
anticoagulant, restarting
anticoagulant, treatment
anticoagulant, treatment in CVD
aortic arch ulcerated plaques
arterial dissection
arterial dissection, carotid
arterial dissection, childhood
arterial dissection, vertebral
aspirin
ataxia
atrial cardiopathy
atrial fibrillation
atrial flutter
atrial septal aneurysm
atrial septal defect
basilar artery occlusion
brainstem, infarction of
brainstem, lesion of
cancer, cerebrovascular accident complicating patients with
cardiac surgery
cardiac surgery, neurologic complications with
cardiomyopathy
cardioseal device
carotid artery disease
CAT scan
CAT scan, angiography
CAT scan, dense artery sign
cavernous hemangioma
cerebellar infarction
cerebral atherosclerosis
cerebral embolism
cerebral embolism, cardiac origin
cerebral embolism, mechanical extraction
cerebral infarction
cerebral ischemia
cerebral venous thrombosis
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, cardiac disease causing
cerebrovascular accident, cryptogenic
cerebrovascular accident, delayed onset
cerebrovascular accident, etiology
cerebrovascular accident, infancy and childhood
cerebrovascular accident, intrauterine
cerebrovascular accident, neonatal
cerebrovascular accident, prevention of
cerebrovascular accident, recurrent
cerebrovascular accident, secondary prevention
cerebrovascular accident, severity
cerebrovascular accident, silent
cerebrovascular accident, without occluded vessel
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular accident, young adult
cerebrovascular disease, risk factors in
children
Clinical Pathologic Conference(C.P.C.)
CLOSURE I trial
clot retrieval
coma
complications
controversies in neurology
coumarin
coumarin, restarting treatment
decerebrate posture
decision analysis
dense basilar artery sign
dense middle cerebral artery sign
doll's head maneuver
dysarthria
echocardiogram
echocardiogram, contrast
echocardiogram, transesophageal
echocardiogram, transthoracic
efficacy
embolic stroke of unknown source
embolism, air
embolism, paradoxical
embolism, vertebral-basilar artery
endarterectomy, carotid
endocarditis
endocarditis, acute bacterial
endocarditis, subacute bacterial
endovascular therapy
endovascular therapy, selection criteria
epidemiology of neurology
evidence-based research
Fabry's disease
fibrinolytic agents
heart valve, prosthetic
hemianopia, homonymous
hypercoagulable state
hyperintense vessel sign
iatrogenic neurologic disorders
INR values
intracerebral hemorrhage
intracerebral hemorrhage, work up
locked-in syndrome
MERCI trial
migraine
misdiagnosis
mobile cardiac outpatient telemetry
mortality
moyamoya
MRI
MRI, abnormal
MRI, FLAIR, hyperintense vessels
MRI, pelvis
MRI, venography
neurologic complications
neurologic complications of, surgery
neurologic disease, diagnoses of
neurologic signs
neurologic symptoms
occipital lobe, infarction
old age, neurology of
patent foramen ovale
patent foramen ovale size
patent foramen ovale, medical treatment
patent foramen ovale, percutaneous closure
patent foramen ovale, surgical treatment of
patient selection
pelvic deep venous thrombosis
Penumbra System
platelet inhibiting drugs
pons, infarction of
practice guidelines
prenatal
prethrombic state, screening for
prevention of neurologic disorders
prognosis
RESPECT trial
Retriever Device
review article
right-left cardiac shunt
risk factors
risk-benefit assessment
safety
sclerotherapy
screening
sickle cell disease
solitaire device
STARFlex septal closure system
superior cerebellar artery infarction
telemetry, cardiac
the metabolic syndrome
thrombectomy
thrombin inhibitor
thrombolysis, mechanical
thrombophlebitis
thrombus, atrial
thrombus, intracardiac
thrombus, mural
tissue plasminogen activator, intravenous
transient ischemic attack
treatment of neurologic disorder
ultrasonography, carotid artery
valvulopathy
varicose veins
vasculitides
vasculopathy
vision, blurred
visual field defect
visual impairment
weakness, generalized
workup
ximelagatran
Showing articles 0 to 50 of 7317 Next >>

Patent Foramen Ovale Management for Secondary Stroke Prevention:State-of-the-Art Appraisal of Current Evidence
Stroke 55:236-247, Sposato,L.A.,et al, 2024

Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke
NEJM 384:970-971, , 2021

Practice Advisory Update Summary: Patent Foramen Ovale and Secondary Stroke Prevention
Neurol 94:876-885, Messe, S.R.,et al, 2020

Evidence-Based Management of Patent Foramen Ovale in Patients with Ischemic Stroke
JAMA Neurol 75:147-148, Kamel, H., 2018

PFO Closure for Cryptogenic Stroke
NEJM 378:1639-1642, Mi, M.Y.,et al, 2018

Patent Foramen Ovale Closure, Antiplatelet Therapy or Anticoagulation Therapy Alone for Management of Cryptogenic Stroke?
BMJ 362:k2515, Kuijpers, T.,et al, 2018

Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
NEJM 377:1022-1032,1006,1093, Saver, J.L.,et al, 2017

Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke
NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017

Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
NEJM 377:1033-1042,1006,1093, Sondergaard, L.,et al, 2017

Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice
Front Neurol 7:1-16, Nouh, A.,et al, 2016

Cryptogenic Stroke
NEJM 374:2065-2074, Saver, J.L., 2016

Closure Versus Medical Therapy for Preventing Recurrent Stroke in Patients with Patent Foramen Ovale and a History of Cryptogenic Stroke or Transient Ischemic Attack
Stroke 47:e188-e189, Li, J.,et al, 2016

The Value of Transesophageal Echocardiography for Embolic Strokes of Undetermined Source
Neuol 87:988-995, Katsanos, A.H.,et al, 2016

Acute Ischemic Stroke in Pediatric Patients
Stroke 46:e32-e33, Mittal, S.O.,et al, 2015

Diagnostic Yield of Pelvic Magnetic Resonance Venography in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Stroke 45:2324-2329, Liberman, A.L.,et al, 2014

Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013

Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
NEJM 368:1083-1091,1152, Meier, B.,et al, 2013

An Index to Identify Stroke-Related vs Incidental Patent Foramen Ovale in Cryptogenic Stroke
Neurol 81:619-625,619, Kent, D.M.,et al, 2013

Patent Foramen Ovale and Cryptogenic Stroke
Stroke 44:2676-2678, Furlan, A.J. and Jauss, M., 2013

Clinicopathologic Conference, Acute Ischemic Stroke due to Basilar Artery Embolism. Patent Foramen Ovale
NEJM 367:1450-1460, Case 31-2012, 2012

Critique of Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
Stroke 43:3147-3149, Thaler, D.E.,et al, 2012

Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke Prevention
Stroke 43:422-431, Kitsios,G.D.,et al, 2012

Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
NEJM 366:991-999,1048, Furlan,A.J.,et al, 2012

Neurological Complications of Sclerotherapy for Varicose Veins
J Vasc Surg 55:243-251, Sarvananthan, T.,et al, 2012

Diagnosing a Patent Foramen Ovale in Children: Is Transesophageal Echocardiography Necessary?
Stroke 42:98-101, Hubail,Z.,et al, 2011

Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:227-276, Furie,K.L.,et al, 2011

Etiologic investigation of ischemic stroke in young adults
Neurol 76:1983-1988, Larrue, V.,et al, 2011

Study Design of the CLOSURE I Trial: A Prospective, Multicenter, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex Septal Closure System Versus Best Medical Therapy in Patients With Stroke or TIA Due to Presumed Paradoxical Embolism Through a PFO
Stroke 41:2872-2883, Furlan,A.J.,et al, 2010

Recurrent Cerebral Ischemia in Medically Treated Patent Foramen Ovale: A Meta-Analysis
Neurol 73:89-97,84, Almekhlafi,M.A.,et al, 2009

Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke 39:2644-2691, Roach,E.S.,et al., 2008

Antithrombotic and Interventional Treatment Options in Cardioembolic Transient Ischaemic Attack and Ischaemic Stroke
JNNP 78:14-24, McCabe,D.J.H. &Rakhit,R.D., 2007

Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 37:577-617, Sacco,R.L.,et al, 2006

Therapeutic Strategies After Examination by Transesophageal Echocardiography in 503 Patients with Ischemic Stroke
Stroke 37:859-864, Harloff,A.,et al, 2006

Closure of Patent Foramen Ovale After Cryptogenic Stroke
Lancet 368:350-352, Wrle,J., 2006

Embolic Stroke Due to a Left Atrial Thrombus Two Years After Placement of an Atrial Septal Defect Closure Device
Am J Cardiol 98:1294-1296, Raghu,A.,et al, 2006

Patent Foramen Ovale in Young Adults with Unexplained Stroke
NEJM 353:2361-2372, Kizer,J.R. &Devereux,R.B., 2005

Patent Foramen Ovale Closure Devices
JAMA 294:366-369, Maisel,W.H.&Laskey,W.K., 2005

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004

Practice Parameter: Recurrent Stroke with Patent Foramen Ovale and Atrial Septal Aneurysm
Neurol 62:1042-1050, Messe,S.R.,et al, 2004

Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients with Patent Foramen Ovale
Stroke 35:2145, Homma,S.,et al, 2004

Incidence and Clinical Course of Thrombus Formation on Atrial Septal Defect and Patent Foramen Ovale Closure Devices in 1,000 Consecutive Patients
J Am Coll Cardiol 43:302-309, Krumsdorf,U.,et al, 2004

Incidence of Thrombus Formation on the CardioSEAL and the Amplatzer Interatrial Closure Devices
Am J Cardiol 93:426-431, Anzai,H.,et al, 2004

Infective Endocarditis Resulting from CardioSEAL Closure of a Patent Foramen Ovale
Catheter Cardiovasc Interv 55:217-220, Goldstein,J.A.,et al, 2002

Stroke Prevention
Neurol Clin 18:321-341, Wein,T.H. &Bornstein,N.M., 2000

Closure of Patent Foramen Ovale for Pardoxical Emboli: Intermediate-Term Risk of Recurrent Neurological Events Following Transcatheter Device Placement
J Am Coll Cardiol 35:1311-1316, Hung,J.,et al, 2000

Preventing Stroke Recurrence in Patients with Patent Foramen Ovale: Antithrombotic Therapy, Foramen Closure, or Therapeutic Abstention? A Decision Analytic Perspective
Am Heart J 135:532-541, Nendaz,M.R.,et al, 1998

Causes and Mechanisms of Cerebellar Infarction in Young Patients
Stroke 28:2400-2404, Barinagarrementeria,F.,et al, 1997

Patent Foramen Ovale and Brain Infarct:Echocardiographic Predictors, Recurrence, and Prevention
Stroke 25:782-786, Hanna,J.P.,et al, 1994



Showing articles 0 to 50 of 7317 Next >>